Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients

The results from our study suggest that a BMI of ≥ 22 kg/m2 is a potential risk factor for tamoxifen-related fatty liver and exercise is a possible protective factor.